1. Gibert CM: Traite Pratique de Maladies de la Peau et de la Syphilis, 3rd edition. Paris, Plon, 1860, p. 402
2. Drago F et al: Human herpesvirus 7 in pityriasis rosea. Lancet 349:1367, 1997
3. Watanabe T et al: Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. J Invest Dermatol 119:793, 2002
4. Broccolo F et al: Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J Invest Dermatol 124:1234, 2005
5. Canpolat Kirac B et al: The role of human herpesvirus 6, human herpesvirus 7, Epstein-Barr virus and cytomegalovirus in the aetiology of pityriasis rosea. J Eur Acad Dermatol Venereol 23:16, 2009
6. Drago F, Vecchio F, Rebora A: Use of high-dose
acyclovir in pityriasis rosea.
J Am Acad Dermatol 54:82, 2006
7. Nanda A, Al-Hasawi F, Alsaleh QA: A prospective survey of pediatric dermatology clinic patients in Kuwait: An analysis of 10,000 cases. Pediatr Dermatol 16:6, 1999
8. Chuh AA et al: Temporal case clustering in pityriasis rosea: A regression analysis on 1379 patients in Minnesota, Kuwait, and Diyarbakir, Turkey. Arch Dermatol 141:767, 2005
9. Chuang TY et al: Pityriasis rosea in Rochester, Minnesota, 1969 to 1978. J Am Acad Dermatol 7:80, 1982
10. Drago F, Broccolo F, Rebora A: Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol 61:303, 2009
11. Drago F et al: Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin. Dermatology 195:374, 1997
12. Drago F et al: Human herpes virus-like particles in pityriasis rosea lesions: An electron microscopy study. J Cutan Pathol 29:359, 2002
13. Watanabe T et al: Human herpesvirus 7 and pityriasis rosea. J Invest Dermatol 113:288, 1999
14. Kosuge H et al: Epidemiological study of human herpesvirus-6 and human herpesvirus-7 in pityriasis rosea. Br J Dermatol 143:795, 2000
15. Kempf W et al: Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol 135:1070, 1999
16. Chuh AA, Chan HH, Zawar V: Is human herpesvirus 7 the causative agent of pityriasis rosea?–A critical review. Int J Dermatol 43:870, 2004
17. Clark DA: Human herpesvirus 6. Rev Med Virol 10:155, 2000
18. Black JB, Pellett PE: Human herpesvirus 7. Rev Med Virol 9:245, 1999
19. Blauvelt A: Skin diseases associated with human herpesvirus 6, 7, and 8 infection. J Invest Dermatol Symp Proc 6:197, 2001
20. Yamanishi K et al: Identification of human herpesvirus-6 as a causal agent for exanthem subitum [see comments]. Lancet 1:1065, 1988
21. Tanaka K et al: Human herpesvirus 7: Another causal agent for roseola (exanthem subitum). J Pediatr 125:1, 1994
22. Asano Y et al: Severity of human herpesvirus-6 viremia and clinical findings in infants with exanthem subitum. J Pediatr 118:891, 1991
23. Hussein MR et al: Phenotypical characteristics of the immune cells in allergic contact dermatitis, atopic dermatitis and pityriasis rosea. Pathol Oncol Res 15:73, 2009
24. Neoh CY et al: Characterization of the inflammatory cell infiltrate in herald patches and fully developed eruptions of pityriasis rosea. Clin Exp Dermatol 35:300, 2010
25. Brazzelli V et al: Pityriasis rosea-like eruption during treatment with
imatinib mesylate: description of 3 cases.
J Am Acad Dermatol 53:S240, 2005
26. Guarneri C, Polimeni G, Nunnari G: Pityriasis rosea during
etanercept therapy.
Eur Rev Med Pharmacol Sci 13:383, 2009
27. Rajpara SN, Ormerod AD, Gallaway L: Adalimumab-induced pityriasis rosea. J Eur Acad Dermatol Venereol 21:1294, 2007
28. Kaymak Y, Taner E: Anxiety and depression in patients with pityriasis rosea compared to patients with tinea versicolor. Dermatol Nurs 20:367, 2008
29. Drago F et al: Pregnancy outcome in patients with pityriasis rosea. J Am Acad Dermatol 58:S78, 2008
30. Amer A, Fischer H, Li X: The natural history of pityriasis rosea in black American children: how correct is the “classic” description? Arch Pediatr Adolesc Med 161:503, 2007
31. Chuh AA et al: Interventions for pityriasis rosea. Cochrane Database Syst Rev CD005068, 2007
32. Sharma PK et al:
Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial.
J Am Acad Dermatol 42:241, 2000
33. Amer A, Fischer H:
Azithromycin does not cure pityriasis rosea.
Pediatrics 117:1702, 2006
34. Bukhari IA: Oral
erythromycin is ineffective in the treatment of pityriasis rosea.
J Drugs Dermatol 7:625, 2008
35. Rasi A, Tajziehchi L, Savabi-Nasab S: Oral
erythromycin is ineffective in the treatment of pityriasis rosea.
J Drugs Dermatol 7:35, 2008
36. Leenutaphong V, Jiamton S: UVB phototherapy for pityriasis rosea: A bilateral comparison study. J Am Acad Dermatol 33:996, 1995